Clinical Trial Update: Investigation of Optimal Dosage Regimen for HRS9531 Tablets in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial to investigate the optimal dosage regimen of the experimental tablet HRS9531 in healthy subjects; study targets overweight/obesity and type 2 diab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• HRS9531

Snippet

Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. | Conditions: Overweight or Obese, Type 2 Diabetes | Phase 1 | Status: NOT_YET_RECRUITING